Znanstveni rad - Pismo
Ruxolitinib treatment improves muscle mass in patients with myelofibrosis
Annals of Hematology, 100 (2021), 4; 1105-1106. https://doi.org/10.1007/s00277-020-04243-8

Lucijanić, Marko; Galušić, Davor; Sorić, Ena; Sedinić, Martina; Ćubela, Marta; Huzjan Korunić, Renata; Pejša, Vlatko; Kušec, Rajko

Citirajte ovaj rad

Lucijanić, M., Galušić, D., Sorić, E., Sedinić, M., Ćubela, M., Huzjan Korunić, R. ... Kušec, R. (2021). Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of Hematology, 100. (4), 1105-1106. doi: 10.1007/s00277-020-04243-8

Lucijanić, Marko, et al. "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis." Annals of Hematology, vol. 100, br. 4, 2021, str. 1105-1106. https://doi.org/10.1007/s00277-020-04243-8

Lucijanić, Marko, Davor Galušić, Ena Sorić, Martina Sedinić, Marta Ćubela, Renata Huzjan Korunić, Vlatko Pejša i Rajko Kušec. "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis." Annals of Hematology 100, br. 4 (2021): 1105-1106. https://doi.org/10.1007/s00277-020-04243-8

Lucijanić, M., et al. (2021) 'Ruxolitinib treatment improves muscle mass in patients with myelofibrosis', Annals of Hematology, 100(4), str. 1105-1106. doi: 10.1007/s00277-020-04243-8

Lucijanić M, Galušić D, Sorić E, Sedinić M, Ćubela M, Huzjan Korunić R, i sur.. Ruxolitinib treatment improves muscle mass in patients with myelofibrosis. Annals of Hematology [Internet]. 04.2021. [pristupljeno 06.12.2024.];100(4):1105-1106. doi: 10.1007/s00277-020-04243-8

M. Lucijanić, et al., "Ruxolitinib treatment improves muscle mass in patients with myelofibrosis", Annals of Hematology, vol. 100, br. 4, str. 1105-1106, Travanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:268065. [Citirano: 06.12.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.